Trade Names:
Synonyms:
Status: Approved (1939)
Entry Type: Oligosaccharide
Molecule Category: Salt
UNII: ZZ45AB24CA
Parent Compound: HEPARIN

Pharmacology

Action Mechanism of Action Reference
ACTIVATOR Antithrombin-III activator ISBN DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Thrombosis 4 D013927 ClinicalTrials
Acute Kidney Injury 3 D058186 ClinicalTrials
Cardiovascular Diseases 3 D002318 ClinicalTrials
Pregnancy 3 D011247 ClinicalTrials
Hip Fractures 3 D006620 ClinicalTrials
Colorectal Neoplasms 3 D015179 ClinicalTrials
Stroke 3 D020521 ClinicalTrials
Wounds and Injuries 3 D014947 ClinicalTrials
Aortic Valve Stenosis 3 D001024 ClinicalTrials
Infections 3 D007239 ClinicalTrials
Myocardial Infarction 3 D009203 ClinicalTrials
Hemorrhage 3 D006470 ClinicalTrials
Venous Thromboembolism 3 D054556 ClinicalTrials
Acute Coronary Syndrome 3 D054058 ClinicalTrials
Renal Insufficiency, Chronic 3 D051436 ClinicalTrials
ST Elevation Myocardial Infarction 3 D000072657 ClinicalTrials
Renal Insufficiency 3 D051437 ClinicalTrials
Bacterial Infections 3 D001424 ClinicalTrials
Heart Diseases 3 D006331 ClinicalTrials
Angina, Stable 3 D060050 ClinicalTrials
Myocardial Ischemia 3 D017202 ClinicalTrials
Colorectal Neoplasms 3 D015179 ClinicalTrials
Renal Insufficiency 3 D051437 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Subarachnoid Hemorrhage 3 D013345 ClinicalTrials
Diabetes Mellitus, Type 2 3 D003924 ClinicalTrials
Coronary Disease 3 D003327 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Myocardial Infarction 3 D009203 ClinicalTrials
Genital Neoplasms, Female 3 D005833 ClinicalTrials
Vitreoretinopathy, Proliferative 3 D018630 ClinicalTrials
Sepsis 3 D018805 ClinicalTrials
Neoplasms 3 D009369 ClinicalTrials
Neoplasms 3 D009369 ClinicalTrials
Burns 2 D002056 ClinicalTrials
Diabetes Mellitus, Type 1 2 D003922 ClinicalTrials
Bacteremia 2 D016470 ClinicalTrials
Shock 2 D012769 ClinicalTrials
Shock, Septic 2 D012772 ClinicalTrials
Pneumonia 2 D011014 ClinicalTrials
Cystitis, Interstitial 2 D018856 ClinicalTrials
Pre-Eclampsia 2 D011225 ClinicalTrials
Infertility 2 D007246 ClinicalTrials
Angina, Unstable 2 D000789 ClinicalTrials
Stomatitis 1 D013280 ClinicalTrials
Thrombophlebitis 1 D013924 ClinicalTrials
Urinary Tract Infections 1 D014552 ClinicalTrials
Obesity 1 D009765 ClinicalTrials
Respiratory Distress Syndrome 1 D012128 ClinicalTrials

Related Entries

Parent
Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Vascular disorders
26.19
Immune system disorders
10.14
General disorders and administration site conditions
9.8
Blood and lymphatic system disorders
7.83
Injury, poisoning and procedural complications
6.95
Nervous system disorders
6.83
Cardiac disorders
5.6
Respiratory, thoracic and mediastinal disorders
4.19
Gastrointestinal disorders
3.62
Investigations
3.13
Infections and infestations
2.78
Skin and subcutaneous tissue disorders
2.32

Cross References

Resources Reference
ChEMBL CHEMBL1201657
FDA SRS ZZ45AB24CA